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Abstract
Purpose The goal of this work was to (i) determine patterns
of progression in glaucomatous visual field loss, (ii)
compare the detection rate of progression between locally
condensed stimulus arrangements and conventional 6°×6°
grid, and (iii) assess the individual frequency distribution of
test locations exhibiting a local event (i.e., an abrupt local
deterioration of differential luminance sensitivity (DLS) by
more than -10dB between any two examinations).
Methods The visual function of 41 glaucomatous eyes of 41
patients (16 females, 25 males, 37 to 75 years old) was
examined with automated static perimetry (Tuebingen Com-
puter Campimeter or Octopus 101-Perimeter). Stimuli were
added to locally enhance the spatial resolution in suspicious
regions of the visual field. The minimum follow-up was four
subsequent sessions with a minimum of 2-month (median
6-month) intervals between each session. Progression was
identified using a modified pointwise linear regression (PLR)
method and a modified Katz criterion. The presence of events
was assessed in all progressive visual fields.
Results Eleven eyes (27%) showed progression over the
study period (median 2.5 years, range 1.3–8.6 years). Six
(55%) of these had combined progression in depth and size
and five eyes (45%) progressed in depth only. Progression
in size conformed always to the nerve fiber course. Seven
out of 11 (64%) of the progressive scotomata detected by
spatially condensed grids would have been missed by the
conventional 6°×6° grid. At least one event occurred in
64% of all progressive eyes. Five of 11 (46%) progressive
eyes showed a cluster of events.
Conclusions The most common pattern of progression in
glaucomatous visual fields is combined progression in depth
and size of an existing scotoma. Applying individually
condensed test grids remarkably enhances the detection rate
of glaucomatous visual field deterioration (at the expense of
an increased examination time) compared to conventional
stimulus arrangements.
Keywords Glaucoma.Progression.Perimetry.
Condensation.Event
Introduction
Glaucomatous visual field progression algorithms assess
changes in local differential luminance sensitivity (DLS)
across time. The appearance of new scotomata or changes
to existing field defects can be monitored across time using
either trend or event analysis. So far, there is no generally
accepted definition for progression of glaucomatous visual
field loss. Trend analyses fit linear regression to DLS
values and compare the obtained slope to the distribution of
slopes from hypothetically non-progressing thresholds.
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in subsequent exams and compare the observed threshold
changes to empiric distributions of threshold changes from
stable glaucoma patients. Both of these approaches are
reasonablesinceaccordingtoearlierstudiesthemostcommon
patternofprogressioninglaucomaisdeepeningofanexisting
scotoma [4, 25, 26], yet the field has not converged upon a
single “gold standard” for visual field progression.
Due to practical considerations of time in the clinic, the
spatial resolution for the detection of glaucomatous changes
in standard automated perimetry has historically been
restricted to a 6°×6° rectangular grid. However, spatially
denser grids can detect glaucomatous defects earlier than
conventional 6°×6° test point arrangements [1, 30, 36, 39].
Local condensation in functionally or morphologically
suspicious areas can enhance spatial resolution without
unreasonably extending the examination duration [30]. The
test grid is condensed within a “region of interest” (ROI) of
the visual field as circumscribed by the clinician. An ROI is
chosen for each patient by consulting neighborhoods of
visual field areas adjacent to their existing scotoma
(Scotoma-Oriented Perimetry, SCOPE) or to the visual
field areas associated with morphologically suspicious areas
as determined by optic disc and nerve fiber layer photo-
graphs (Fundus-Oriented Perimetry = FOP). In addition to
improving the detection of glaucomatous visual field loss,
local condensation of stimuli could be a useful approach for
monitoring disease progression.
To our knowledge, this is the first study to analyze the
patterns of visual field defect (VFD) progression in
glaucoma with locally condensed stimulus arrangements.
The aims of this study are to (i) determine the patterns of
progression in glaucomatous visual field defects, (ii)
compare the detection rate of VFD progression of locally
condensed grids with that of a conventional 6°×6° grid and
(iii) assess the individual frequency of test locations
exhibiting a local event.
Materials and methods
Patients
Progression in conventional and condensed test grids was
analyzed retrospectively in 41 eyes of 41 patients (16
females, 25 males) from the Tuebingen University Eye
Hospital with adequately treated glaucoma stage 1 or higher
according to Mills classification [27]: 34 had primary open-
angle glaucoma, four had low-tension glaucoma, one had
pigmentary glaucoma and two glaucomas could not be
classified. Ages ranged between 37 and 75 years (median
60 years). All patients had ∣<8 ∣ Dsph; ∣<3 ∣ Dcyl; best
refracted central visual acuity > 10/20; no relevant opacities
of the central refractive media; no history or signs of other
optic neuropathies or other diseases affecting the visual
field than glaucoma, and were not receiving miotic drugs.
Patients with advanced optic disc cupping that exceeded
two clock hours were excluded from this study to avoid a
floor effect, i.e., further progression may not be detectable
in these areas due to end-stage visual field loss. Further-
more, patients with abnormalities of the anterior chamber as
determined by gonioscopy (Goldmann 3 mirror contact
lens), or at risk of an angle closure were excluded from this
study. Fundus morphology was assessed with direct
ophthalmoscope using red-free illumination and indirect
fundus lens (78 D or 90 D) at the slit lamp. The protocol
adhered to the tenets of the Declaration of Helsinki.
All patients had a manifest glaucoma according to the
European Glaucoma Society (EGS) criterion [9]w i t h
unequivocal glaucomatous alterations of optic nerve head
morphology and/or retinal nerve fiber layer (RNFL), and
manifest visual field defects. Glaucomatous optic nerve head
morphologywascharacterizedusingstereophotographs,with
glaucomatous alterations defined by diffuse thinning or focal
notching of the neuroretinal rim, deviation from the ISNT
rule [19], vertical cup/disc ratio exceeding 0.6, optic disc
hemorrhage[s], or bared circumlinear vessels. Glaucomatous
RNFLdefectsweredefinedas wedge-shaped,circumscribed,
or focal losses.
Visual fields
Examinations were conducted with threshold-estimating
static, standard automated perimetry (full-threshold 4-2-1
strategy, with at least three reversals) in a minimum of four
subsequent sessions (one baseline session and three follow-up
sessions). All 41 eyes were initially examined with the
Tuebingen Computer Campimeter (TCC, manufactured at the
Tuebingen University Eye Hospital). Thirty-two eyes finished
the sessions before the TCC was replaced with the Octopus
101. The remaining nine eyes from autumn 2003 onward were
tested with the Octopus 101 perimeter (Haag-Streit Inc.,
Koeniz, Switzerland). For both perimeters, a grid similar to
the Humphrey pattern 30-2, with DLS values obtained in 72
locations spaced according to a 6°×6° grid was used.
The TCC used a video display unit as opposed to the
cupola used by the Octopus 101. The Tuebingen group had
previously determined age-related normative values for
both the TCC (about 1996) and Octopus 101 perimeter as
an order of the manufacturer Haag-Streit. A subgroup was
tested on both devices, and since the difference of DLS at
all test points was less than 1 dB, transformation of the
normative values of the Octopus 101 instrument was
unnecessary for comparison to the TCC [17].
In all visual field examinations, additional test points
were inserted between the original “coarse” stimulus
1660 Graefes Arch Clin Exp Ophthalmol (2009) 247:1659–1669arrangements. Regions of interest (ROI) were defined by
the examiner to locally enhance spatial resolution in visual
field areas related to anatomically suspicious regions like
notches, hemorrhages, and circumscribed RFNL defects or
related functionally to circumscribed visual field defects
(Fig. 1). ROIs were defined as the area surrounding at least
three visual field test locations with p-values<0.05 (accord-
ing to the TD plot) in the relating upper or lower hemifield
taking the course of the nerve fibers into consideration.
Normal visual field test locations of the original 6°×6° grid,
adjacent to the pathological locations, were included in the
ROI. The defined region was filled with subsets of a
stimulus arrangement with high spatial resolution (grid with
191 stimuli, see Fig. 1) to increase the density of test points
within the ROI. The total number of test points did not
exceed 160. The individually specified locally condensed
grids remained the same during the whole follow-up period
in all patients.
Due to the increased number of test locations, the visual
field examination was completed in two sub-sessions
within a time window of 24 h. The locally condensed grid
was split into two complementary randomized subsets with
an approximately equal number of test points to achieve
reasonable examination durations for the two sessions. Nine
identical stimulus locations were tested in both subgrids to
control for intersession variability. This procedure was
carried out according to a former publication [30] address-
ing this quality assurance.
Patterns of progression
Scotomata in baseline exams were defined as clusters of at
least three contiguous visual field locations ((TD, p<0.05,
with at least one p<0.01) [27]). Any two visual field
locations were considered as contiguous if they were
neighbored in vertical, horizontal, or oblique direction
within the 6°×6° distance. Progression was analyzed using
trend analyses. A progressing visual field series was
defined by the presence of a cluster of at least three
contiguous, progressive, non-edge test points [20, 35] not
crossing the horizontal midline [38] in two consecutive
examinations in at least two of the same test locations
according to the standards of the European Glaucoma
Prevention Study [24]. Progressing visual fields series were
assessed for the patterns in which their locations progressed
relative to the initial scotomata. Progression of existing
scotoma could occur in depth, size, or both depth and size.
Local progression exclusively in depth was assumed if
progressive test locations were contained within the initial
scotoma cluster (red triangle symbol, Fig. 2). Exclusive
local progression in size was assumed if progressive test
locations occurred in locations (normal at baseline) adjacent
to the initial scotoma cluster (red triangle and red frame
symbol,Fig.2). In addition to changes to existing scotomata,
the occurrence of a new scotoma was assumed if there
appeared a cluster of at least three pathological test points
(TD, p<0.05 with at least one p<0.01) [27]w i t h i na n
initially normal area not adjacent to a previously identified
scotoma.
The detection rate of progression in locally condensed
grids was compared to the 6°×6° grid. The 95%-confidence
intervals (CI) were computed for the proportion of pro-
gressions that were detected with the help of the additional
grid points. To determine whether the higher sensitivity of
spatially condensed grids was bought at the expense of
specificity,eyeswereflaggedifthesessionimmediatelyafter
the first two consecutive sessions indicating progression did
not reconfirm the confirmed progression. This criterion is
Fig. 1 The 6×6° grid (a) was condensed in the region of interest (b) to achieve an individual locally condensed grid (c)
Graefes Arch Clin Exp Ophthalmol (2009) 247:1659–1669 1661Fig. 2 Example of progression in depth and size (16 visits within
9 years). The test locations with confirmed progression are marked
with red triangles. The initially normal and later pathologic test
locations are marked with red frames. The four examples show the
four different test point courses: (a) stable (b) variable (c) progression
(d) improvement. The events are marked with red and green clasps in
the test points and with red and green bars in the inset (b). The nearly
horizontal blue lines show the age-related normative DLS values at the
selected stimulus locations. The red lines show the 95% CI. Blue
circles highlight five progressive stimulus locations. Three of these
non-edge locations are adjacent, i.e., they form a cluster with the
distances less than or equal to the distances of the 6°×6° rectangular
Humphrey grid. Therefore, this set of visual fields record is classified
as progressive
1662 Graefes Arch Clin Exp Ophthalmol (2009) 247:1659–1669similar to that used in the final protocol of the Ocular
Hypertension Treatment Study (OHTS) [21].
Progression trend analyses
To determine progression using trend analyses, in this study
a modified pointwise linear regression (PLR) was applied
for each test location [10]. It consisted of assuming one
fixed variance for all eyes. That was necessary, as PLR was
attempted with series that were too short to estimate variance
as well as slope. Single locations were indicated as
progressing if the slope of their regression was significantly
below zero (p<0.05), taking into account the magnitude of
slope, the intersession time intervals, the number of
sessions, and the time span of follow-up, and the scatter
of DLS values over time: The shorter the follow-up and the
fewer the examinations, the greater was the slope needed
for the location to be flagged as progressing. Progression
cut-offs using this regression technique are summarized in
Table 1. For example, a slope exceeding –1 dB/year when
examining the visual field once a year for 5 years is flagged
as progressing. Also, a slope exceeding –1.6 dB/ year is
flagged as progressing if the subject had come in 6-month
intervals for a 3-year follow-up period.
The mediantimeto detection ofprogressionwithspatially
condensed grids was compared to that with the 6°×6° grid.
Event analyses
Event analyses were additionally employed to assess abrupt
changes oflocal DLSatany testlocationduringthe follow-up
sessions. At present, there is no generally accepted cut-off
level for a progressive event, i.e., a critical magnitude of local
test-retest DLS difference that warrants suspicion of glau-
comatous progression. To obtain a cut-off, the frequency
distribution of DLS test-retest differences for 86 suitable
patients from the Tuebingen visual fields’ database at all test
locations between the third and fourth visual field examina-
tionswasassessed(Fig.3) The distribution was found to be a
mixture of two central Laplace-distributions. The lower 5%-
quantile, –10 dB, of the more spread out distribution was set
as criterion for a local perimetric event. The parameters of
the Laplace-distributions were interpreted as expected
absolute difference in stable and instable locations, and were
estimated by maximum likelihood procedures.
Thus an event was defined as an abrupt local deteriora-
tion of DLS by more than –10 dB between any two
examinations (Figs. 2, 3). Additionally, clusters of events
were evaluated (for definition of a “cluster”, see above).
Furthermore we assessed the events inside/outside a ROI
and inside a cluster.
The study was carried out and evaluated according to the
following five methodological standards set by Harper et al.
(numbering according to Harper et al.) [12]: (1) specification
of the spectrum composition, i.e., specification of the age,
sex, initial disease stage, and the eligibility criteria; (2)
avoidance of work-up (verification) bias, i.e., all patients
were studied with both conventional and spatially condensed
grids; (3) avoidance of review bias, i.e., both grids were
analyzed independently; (4) presentation of precision of
results for test accuracy for the most important results,
i.e., 95% CI is reported in comparison of detection of
progression with conventional and condensed grids; and (5)
reporting of indeterminate test results was not an issue since
no indeterminate test results existed.
Results
Visual fields
We examined 260 visual fields of 41 eyes (four to 15 fields/
patient, median five fields/patient). Median follow-up
Table 1 Slope criteria for progressing test points depending on test
interval and follow-up period
Test interval Follow-up period [years] Slope [dB/year]
Every 12 months 2.0 - 3.0
3.0 - 1.9
4.0 - 1.3
5.0 - 1.0
6.0 - 0.8
7.0 - 0.6
8.0 - 0.5
9.0 - 0.5
Every 6 months 1.0 - 5.9
1.5 - 3.8
2.0 - 2.7
2.5 - 2.0
3.0 - 1.6
3.5 - 1.3
4.0 - 1.1
4.5 - 0.9
5.0 - 0.8
5.5 - 0.7
6.0 - 0.6
6.5 - 0.6
7.0 - 0.5
7.5 - 0.5
8.0 - 0.4
8.5 - 0.4
9.0 - 0.4
9.5 - 0.3
Graefes Arch Clin Exp Ophthalmol (2009) 247:1659–1669 1663period was 2.5 years (range: 1.3 to 8.6 years) and median
interval between the examinations was 6 months (range 2–
29 months).
According to the Mills [27] glaucoma staging system,
the scotoma had the following stages at the initial session:
22 (54%) as early (stage 1), 11 eyes (27%) as moderate (stage
2), five eyes (12%) as advanced (stage 3), and three eyes
(7%) as severe (stage 4). Mean deviation (MD) ranged from
+1.6 to –8.6 dB (mean –1.8 dB) and Loss Variance (LV) from
2 . 0t o5 0 . 7d B
2 (mean 19.5 dB
2) at the initial session. Mean
change in MD during the follow-up in the progressive group
was +0.41 dB (range +4.3 to –5.5 dB).
Total durationof one visual field examination (subdivided
into two sub-sessions) varied from 31.6 min to 52.6 min
(median 41.5 min, 20.8 min per session) including a break of
approximately 10 min, which was not exactly recorded. We
selected the subjects’ third visit as representative for the
examination times. Intersession variability (“Medium term
fluctuation”) turned out to be in the range of 1% of the total
variation [30].
Patterns of progression
Confirmed progression of a visual field area with spatially
condensed grid occurred in 11 (27%) out of the 41 eyes. Of
these eyes with visual field area progression, six of the 11
(55%) revealed a combined progression in depth and size.
In five eyes (45%), there was deterioration exclusively in
depth. There were no new scotomata or exclusive progres-
sion in size. Of the 30 eyes that did not meet our
progression criterion, a progressive “cluster” was found in
16 eyes (53%) whose presence was not confirmed in
subsequent examinations. No progressive “clusters” could
be found in visual field series of 14 eyes (34%, 81 visual
field examinations).
We evaluated further the type of progression in the 11
eyes showing confirmed progression in a visual field area.
There were altogether 198 progressive test locations: 183
(92%) of them were located inside the ROIs, 49 (25%) of
them were initially normal, indicating progression in size,
and 154 (78%) of all progressive test locations were located
within progressive clusters. Only one eye was flagged with
a negative test occurring after two consecutive positive
tests.
Progression trend analysis
Only four of the 11 progressive cases detected with
spatially condensed grids would have been detected by
applying the 6°×6° grid only (improvement by 7/11, 95%
CI 0.35 to 0.92). The delay from the detection of
progression with condensed grids to that with the 6°×6°
Fig. 3 a Box-and-whiskers plot
and histogram of 10,537 differ-
ences between individual local
DLS thresholds at third and
fourth examination. Small grey
circles indicate values outside
the inner fence. Vertical ticks on
the whiskers mark the 0.5%-,
2.5%-, 10%-, 90%-, 97.5%-, and
99.5% quantiles. The smooth
red line is the density of the
mixture of 23.6% of a central
Laplace-distribution with
parameter 4.35 and 76.4% of a
central Laplace-distribution with
parameter 1.35. b Densities of
the mixture (red encompassing)
and its components (symmetric
triangles) with a shaded area
that represents 5% of the area
under the solid symmetric
triangle, when the density axis
is not logarithmic. DLS
differences in that area are
considered events
1664 Graefes Arch Clin Exp Ophthalmol (2009) 247:1659–1669grid varied from 0 to 41 months or from 0 to 5 visits.
Kaplan-Maier curves showing the time to detection of
progression for both grids are shown in Fig. 4.
When all 11 progressions had been detected by SCOPE,
at six visits or 32 months, just one progression would have
been detected using the 6°×6° grid while it took ten visits
or 73 months, until 4/11 were detected using the 6°×6° grid
(Fig. 5). When using Kaplan-Meier estimation, the median
time gain through condensed grids was estimated to be six
visits (lower limit of 95% CI two visits) or 41 months
(lower limit of 95% CI 19 months).
Events
Events were defined as a drop in DLS in a subsequent
session. The event criterion was set to the 5%-quantile of
the distribution of instable locations, i.e., to –10 dB. The
frequency distribution of 10,537 DLS test-retest differences
for 86 suitable patients from the Tuebingen visual fields’
database with 530 visual fields of the third and fourth
examinations is shown in Fig. 3. The mean of absolute
differences was estimated to be 1.35 dB in stable locations
and 4.35 dB in instable locations.
Events by more than –10 dB were seen in seven (64%)
of the 11 eyes showing progression evaluated with trend
analyses. Events occurred in 57 test locations during the
follow-up period: 82% (47 of 57) of these events were
located inside the ROIs, and 60% (28 of 47) of these inside
a progressive cluster. A cluster of three or more contiguous
events that was confirmed within the subsequent 2 years
appeared in five of the 11 progressing eyes. In eyes without
trend progression we found ten events inside the ROIs, and
no events outside the ROIs.
Discussion
Identifying progressive glaucomatous visual field defect
remains a challenging task due to wide-ranging individual
intra- and inter-test variability and due to the large number
of different methods of progression analysis and different
criteria for progression [10, 20, 23, 34]. Detection of
progression at the earliest possible point in time in a sight-
threatening disease is essential for an adequate onset and
adjustment of therapeutic strategies. Delay between the
clinical detection of nerve fiber atrophy and observing the
defect in the visual field using conventional perimetry is up
to 6 years [33]. In addition to using modern progression
analyses techniques [29, 37], this delay can be shortened
using stimulus arrangements with higher spatial resolution
[1, 30, 36, 39]. This is possible clinically, e.g., with the
Octopus 101 instrument thatallows for the generation ofuser-
defined individual test point arrangements, referring to a
smoothmodelofanage-correctednormalhillofvision,which
is in contrast to the Humphrey Field Analyzer. Taking into
accountthatglaucomatousvisualfielddefectstendtoprogress
in already damaged areas of the visual field [4, 25, 28], it is
reasonable to locally condense the grid in individually
specified regions at increased risk of progression.
In a recent paper [30], we showed that locally condensed
test grids significantly increase the detection rate of
glaucomatous visual field loss in comparison to conven-
tional 6°×6° grids. This study is intended to demonstrate
that local grid condensation also enhances detection of
progression of glaucomatous visual field loss.
The patternsofglaucomatousvisual field progression found
in this study did not differ remarkably from those identified
with conventional grids in earlier studies despite of differences
in study cohorts and progression criteria: The initial stage of
glaucoma in Boden’s[ 4] cohort was mild in about one-third
and moderate in about two-thirds of cases, whereas in our
cohort, about half had a mild glaucoma and half had moderate
or severe glaucoma (corresponding to Mills IV) [27].
Mikelberg et al. [25] had included only progressive visual
fields in their study. In Mikelberg’s study there occurred also
new scotomata, possibly due to longer follow-up.
In general, the expansion of the visual field defects
conformed to the nerve fiber course in the retina. These
findings agree with the results of Pascual et al. [28] and
Fig. 4 Time for the first detection of progression for each grid.
Locally condensed grids detect progression earlier than the 6°×6°
grid. Minimum follow–up time was 16 months, mean follow-up time
was 30 months (2.5 years)
Graefes Arch Clin Exp Ophthalmol (2009) 247:1659–1669 1665with structural progression in glaucoma [36]. Glaucoma is
known to proceed slowly, and thus longer follow-up
periods and larger study cohorts are needed to achieve
more exact comparisons of the patterns of progression
using different criteria for progression.
Despite a short follow-up, we could detect a consider-
able number of progressive visual fields in our current
cohort. The progression rate of 27% after 3 years of follow-
up was high compared to earlier reports: In the Early
Manifest Glaucoma Trial (EMGT) [3], the progression rate
was 69% during 8 years (median) of follow-up. The
criterion used in this study to identify progressive visual
fields called for a cluster of three progressive test locations.
This is a commonly used criterion as published by Katz
et al. [20]. The AGIS study uses this criterion as well [35].
This criterion can be made more stringent by requiring a
cluster of four progressive test locations, which was used as
criterion for a suspicion of visual field progression in the
Canadian Glaucoma Study (CGS) [7]. That rate was 43.5%
after 8 years of follow-up in the CGS. Tightening the
criterion would result in reducing the rate of progressive
visual fields to 17% within 3 years in our cohort. However,
when taking into account our finding that conventional
grids find less than half of the progressive visual fields
confirmed with spatially condensed grids, the progression
rate of these earlier mentioned studies would presumably
have been higher, if a grid with local test point condensa-
tion had been applied.
The appearance of clusters of abrupt “events” in more
than one-third of the eyes showing progression by trend
analysis suggests that such events may precede local
progression, indicate a more rapid manifestation of glauco-
ma, or both. Observing (and when necessary responding to)
“events” by increasing the frequency of visual field testing
[18] or even intensifying the treatment of these patients
could be worthwhile. In this study, an “event” was defined
to be a sudden deterioration of more than –10 dB, a value
that exceeds normal test-retest variability. Using a fixed
criterion for all locations may not be appropriate since the
test-retest variability is strongly dependent on the initial
defect depth and the eccentricity of the test points under
consideration [14]. However, any problems with using a
fixed dB cut-off value should affect both the conventional
and condensed grids equally since they contain similar
locations and cover the same central 30° of the visual field.
Most of the progressive test locations and events were
situated inside the operator-defined ROI and were concen-
trated in the progressive clusters. Therefore, it is reasonable
to assess potential progression in anatomically (e.g., optic
nerve head or nerve fiber layer) or perimetrically (i.e., areas
of earlier defects in the visual field) suspicious areas using
spatially condensed test locations. However, applying
locally condensed grids may not enhance the detection of
diffusely progressive losses that do not have a scotoma-
related clue for placement of the ROI.
Cataract formation can cause problems in determining
progression of the scotomata, especially when using a TD
plot instead of the pattern deviation plot that corrects for
overall changes in visual field sensitivity. We decided to
refer to the TD plot, since it has been shown to be more
sensitive in detecting glaucomatous visual field progression
[2]. The effect of cataract formation in the visual fields of
glaucoma patients varies considerably between studies [5,
6, 32]. It has been shown that patients with mild or early
scotomata tend to have a greater fall in the MD values due
to cataract formation than patients with deeper scotomata
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Mean reaction time: --
Classification: No classification applied
Pupil diameter:
Fixation during examination
0.0 0.0 0.0 0.0 0.0 0.0
0.0
2.0
4.0
[min]
[mm]
-2.0
2.0
6.0
10.0
14.0
18.0
> =5%
<5%
<2%
<1%
<0 . 5%
10˚ 20˚ 30˚ 31
Octopus 101 / tAS / Version 2.0.8 / 2.2.14 (2007)
tAS
Threshold determinating perimetry Octopus 101
defect depth [dB]
p-values [%]
defect depth / p-Werte
S., H.
*1927 (73 y.)
female
SAP 4195582
OS
30˚
Time 09:11 09:36 h
Duration (total / netto) 20:34/20:34 21:45/21:45 m:s
Hintergrund-LD: 10 cd/m≤
Answ. wait. time: adaptive
Present.-d.:200 ms
Stimulus size: III
White / White
VA
Correction +0.00 sph +0.00 cyl 0˚
Grid: 1215LA 0/1
Nb of questions
Nb of test locations 74 74
Threshold estimating (with TCC)
Schrittweite: 4-2-1
Vorzeichenwechsel: 4
Max. Anzahl Fragen: 15
Fix 0/22 (0%)(24dB), 0/20 (0%)(27dB)
FP 0/24 (0%), 1/25 (4%)
FN 1/23 (4%), 0/28 (0%)
SF -- --
MF 1.1
MS 22.7
MD 0.8
LV 5.2
CLV 5.0
Area 954 (2152)
Volume 2334 (892)
Startwerte --
Mean reaction time: --
Classification: No classification applied
Pupil diameter:
Fixation during examination
0.0 0.0 0.0 0.0 0.0 0.0
0.0
2.0
4.0
[min]
[mm]
-2.0
2.0
6.0
10.0
14.0
18.0
>= 5 %
<5%
<2%
<1%
<0 . 5%
10˚ 20˚ 30˚ 29
Octopus 101 / tAS / Version 2.0.8 / 2.2.14 (2007)
tAS
Threshold determinating perimetry Octopus 101
defect depth [dB]
p-values [%]
defect depth / p-Werte
S., H.
*1927 (74 y.)
female
SAP 4195582
OS
30˚
Time 09:41 10:36 h
Duration (total / netto) 24:04/24:04 18:44/18:44 m:s
Hintergrund-LD: 10 cd/m≤
Answ. wait. time: adaptive
Present.-d.:200 ms
Stimulus size: III
White / White
VA
Correction +0.00 sph +0.00 cyl 0˚
Grid: 1215LA 0/1
Nb of questions
Nb of test locations 74 74
Threshold estimating (with TCC)
Schrittweite: 4-2-1
Vorzeichenwechsel: 4
Max. Anzahl Fragen: 15
Fix 0/28 (0%)(23dB), 1/26 (4%)(24dB)
FP 1/31 (3%), 0/25 (0%)
FN 2/24 (8%), 4/22 (18%)
SF -- --
MF 1.5
MS 20.1
MD 3.3
LV 20.7
CLV 20.1
Area 1527 (2152)
Volume 5710 (5118)
Startwerte --
Mean reaction time: --
Classification: No classification applied
Pupil diameter:
Fixation during examination
0.0 0.0 0.0 0.0 0.0 0.0
0.0
2.0
4.0
[min]
[mm]
-2.0
2.0
6.0
10.0
14.0
18.0
>= 5 %
<5%
<2%
<1%
<0 . 5%
10˚ 20˚ 30˚ 31
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tAS
Threshold determinating perimetry Octopus 101
defect depth [dB]
p-values [%]
defect depth / p-Werte
S., H.
*1927 (74 y.)
female
SAP 4195582
OS
30˚
Time 08:45 09:23 h
Duration (total / netto) 22:04/22:04 23:21/23:21 m:s
Hintergrund-LD: 10 cd/m≤
Answ. wait. time: adaptive
Present.-d.:200 ms
Stimulus size: III
White / White
VA
Correction +0.00 sph +0.00 cyl 0˚
Grid: 1215LA 0/1
Nb of questions
Nb of test locations 74 74
Threshold estimating (with TCC)
Schrittweite: 4-2-1
Vorzeichenwechsel: 4
Max. Anzahl Fragen: 15
Fix 10/31 (32%)(27dB), 26/27 (96%)(30dB)
FP 1/32 (3%), 1/26 (4%)
FN 0/21 (0%), 1/22 (5%)
SF -- --
MF 0.7
MS 22.2
MD 1.1
LV 10.0
CLV 9.9
Area 1043 (2152)
Volume 2427 (1079)
Startwerte --
Mean reaction time: --
Classification: No classification applied
Pupil diameter:
Fixation during examination
0.0 0.0 0.0 0.0 0.0 0.0
0.0
2.0
4.0
[min]
[mm]
-2.0
2.0
6.0
10.0
14.0
18.0
>= 5 %
<5%
<2%
<1%
<0 . 5%
10˚ 20˚ 30˚ 30
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tAS
Threshold determinating perimetry Octopus 101
defect depth [dB]
p-values [%]
defect depth / p-Werte
S., H.
*1927 (75 y.)
female
SAP 4195582
OS
30˚
Time 10:30 11:17 h
Duration (total / netto) 22:53/22:53 24:41/24:41 m:s
Hintergrund-LD: 10 cd/m≤
Answ. wait. time: adaptive
Present.-d.:200 ms
Stimulus size: III
White / White
VA
Correction +0.00 sph +0.00 cyl 0˚
Grid: 1215LA 0/1
Nb of questions
Nb of test locations 74 74
Threshold estimating (with TCC)
Schrittweite: 4-2-1
Vorzeichenwechsel: 4
Max. Anzahl Fragen: 15
Fix 0/24 (0%)(25dB), 0/28 (0%)(24dB)
FP 0/19 (0%), 2/30 (7%)
FN 2/24 (8%), 3/20 (15%)
SF -- --
MF 0.9
MS 20.9
MD 2.3
LV 21.0
CLV 20.8
Area 1052 (2152)
Volume 3681 (2316)
Startwerte --
Mean reaction time: --
Classification: No classification applied
Pupil diameter:
Fixation during examination
0.0 0.0 0.0 0.0 0.0 0.0
0.0
2.0
4.0
[min]
[mm]
-2.0
2.0
6.0
10.0
14.0
18.0
>= 5 %
<5%
<2%
<1%
<0 . 5%
10˚ 20˚ 30˚ 36
31 23
32 31
Octopus 101 / tAS / Version 2.0.10 / 2.2.14 (2007)
tAS
Threshold determinating perimetry Octopus 101
defect depth [dB]
p-values [%]
defect depth / p-Werte
S., H.
*1927 (76 y.)
female
SAP 4195582
OS
30˚
Time 10:39 11:53 h
Duration (total / netto) 27:18/23:24 29:33/23:36 m:s
Hintergrund-LD: 10 cd/m≤
Answ. wait. time: 800 ms
Present.-d.:200 ms
Stimulus size: III
White / White
VA
Correction
0.8
+1.25 sph +0.00 cyl 0˚
Grid: 1215LA 0/1
Nb of questions
Nb of test locations 74 75
Threshold determinating (tAS)
Schrittweite: 4-2-1
Weitere Antwortwechsel: 1
Max. Anzahl Fragen: 10
Fix 0/140/29 (0%)(26dB)
FP 1/14 (7%), 0/28 (0%)
FN 0/14 (0%), 4/28 (14%)
SF 1.1 0.1
MF 4.7
MS 23.5
MD 0.2
LV 36.8
CLV 34.7
Area 549 (2152)
Volume 3192 (-2663)
Startwerte --
Mean reaction time: --
Classification: No classification applied
Pupil diameter:
Fixation during examination
0.0 0.0 0.0 0.0 0.0 0.0
0.0
2.0
4.0
[min]
[mm]
-2.0
2.0
6.0
10.0
14.0
18.0
>= 5 %
<5%
<2%
<1%
<0 . 5%
10˚ 20˚ 30˚ 31
27 24
31 28
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tAS
Threshold determinating perimetry Octopus 101
defect depth [dB]
p-values [%]
defect depth / p-Werte
S., H.
*1927 (77 y.)
female
SAP 4195582
OS
30˚
Time 09:27 10:19 h
Duration (total / netto) 16:30/14:07 16:52/14:07 m:s
Hintergrund-LD: 10 cd/m≤
Answ. wait. time: 800 ms
Present.-d.:200 ms
Stimulus size: III
White / White
VA
Correction
0.7
+2.75 sph -1.75 cyl 5˚
Grid: 1215LA 0/1
Nb of questions
Nb of test locations 74 75
4-2-1
Fix 1/11 (9%)(25dB), 0/10 (0%)(24dB)
FP 0/11 (0%), 0/11 (0%)
FN 1/9 (11%), 1/10 (10%)
SF 0.7 1.1
MF 3.5
MS 19.6
MD 4.0
LV 59.4
CLV 59.2
Area 990 (2152)
Volume 6440 (3933)
Startwerte --
Mean reaction time: --
Classification: Nerve fibre layer defects; Aulhorn II - Absolute defects without connection to the Blind Spot
Pupil diameter:
Fixation during examination
0.0 0.0 0.0 0.0 0.0 0.0
0.0
2.0
4.0
[min]
[mm]
-2.0
2.0
6.0
10.0
14.0
18.0
>= 5 %
<5%
<2%
<1%
<0 . 5%
10˚ 20˚ 30˚ 31
26 21
29 28
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tAS
Threshold determinating perimetry Octopus 101
defect depth [dB]
p-values [%]
defect depth / p-Werte
S., H.
*1927 (78 y.)
female
SAP 4195582
OS
30˚
Time 11:12 12:09 h
Duration (total / netto) 19:07/17:29 15:20/14:21 m:s
Hintergrund-LD: 10 cd/m≤
Answ. wait. time: 800 ms
Present.-d.:200 ms
Stimulus size: III
White / White
VA
Correction
0.7
+3.00 sph -1.75 cyl 5˚
Grid: 1215LA 0/1
Nb of questions
Nb of test locations 74 75
Threshold determinating (tAS)
Schrittweite: 4-2-1
Weitere Antwortwechsel: 1
Max. Anzahl Fragen: 10
Fix 0/15 (0%)(24dB), 0/10 (0%)(23dB)
FP 1/12 (8%), 0/9 (0%)
FN 1/13 (8%), 2/11 (18%)
SF 0.1 0.0
MF 5.4
MS 17.9
MD 5.7
LV 68.4
CLV 64.3
Area 1166 (2152)
Volume 8591 (7025)
Startwerte --
Mean reaction time: --
Classification: Nerve fibre layer defects; Aulhorn II - Absolute defects without connection to the Blind Spot
Pupil diameter:
Fixation during examination
0.0 0.0 0.0 0.0 0.0 0.0
0.0
2.0
4.0
[min]
[mm]
-2.0
2.0
6.0
10.0
14.0
18.0
>= 5 %
<5%
<2%
<1%
<0 . 5%
10˚ 20˚ 30˚ 31
27 20
30 30
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tAS
Threshold determinating perimetry Octopus 101
defect depth [dB]
p-values [%]
defect depth / p-Werte
S., H.
*1927 (78 y.)
female
SAP 4195582
OS
30˚
Time 09:01 10:17 h
Duration (total / netto) 13:23/13:10 12:37/12:37 m:s
Hintergrund-LD: 10 cd/m≤
Answ. wait. time: 1200 ms
Present.-d.:200 ms
Stimulus size: III
White / White
VA
Correction
0.6
+2.50 sph -1.75 cyl 5˚
Grid: 1215LA 0/1
Nb of questions
Nb of test locations 74 75
4-2-1
Fix 0/10 (0%)(26dB), 0/10 (0%)(24dB)
FP 1/10 (10%), 0/10 (0%)
FN 0/11 (0%), 1/9 (11%)
SF 0.5 0.0
MF 4.5
MS 17.6
MD 5.9
LV 70.0
CLV 68.4
Area 1098 (2152)
Volume 8321 (6543)
Startwerte --
Mean reaction time: --
Classification: Nerve fibre layer defects; Aulhorn II - Absolute defects without connection to the Blind Spot
Pupil diameter:
Fixation during examination
0.0 0.0 0.0 0.0 0.0 0.0
0.0
2.0
4.0
[min]
[mm]
-2.0
2.0
6.0
10.0
14.0
18.0
>= 5 %
<5%
<2%
<1%
< 0.5 %
10˚ 20˚ 30˚ 34
27 23
31 31
Octopus 101 / tAS / Version 2.2.3 / 2.2.14 (2007)
tAS
Threshold determinating perimetry Octopus 101
defect depth [dB]
p-values [%]
defect depth / p-Werte
S., H.
*1927 (78 y.)
female
SAP 4195582
OS
30˚
Time 10:00 10:47 h
Duration (total / netto) 20:06/13:46 10:12/10:12 m:s
Hintergrund-LD: 10 cd/m≤
Answ. wait. time: 1200 ms
Present.-d.:200 ms
Stimulus size: III
White / White
VA
Correction
0.7
+2.50 sph -1.75 cyl 5˚
Grid: 1215LA 0/1
Nb of questions
Nb of test locations 74 75
4-2-1
Fix 0/110/9 (0%)(28dB)
FP 0/11 (0%), 0/9 (0%)
FN 0/11 (0%), 0/9 (0%)
SF 0.4 2.2
MF 5.1
MS 18.3
MD 5.1
LV 80.6
CLV 76.5
Area 899 (2152)
Volume 7585 (4535)
Startwerte --
Mean reaction time: --
Classification: Nerve fibre layer defects; Aulhorn III - Absolute defects with connection to the Blind Spot
Pupil diameter:
Fixation during examination
0.0 0.0 0.0 0.0 0.0 0.0
0.0
2.0
4.0
[min]
[mm]
-2.0
2.0
6.0
10.0
14.0
18.0
> =5%
<5%
<2%
<1%
<0 . 5%
10˚ 20˚ 30˚ 30
Octopus 101 / tAS / Version 2.2.6 / 2.2.14 (2007)
tAS
Threshold determinating perimetry Octopus 101
defect depth [dB]
p-values [%]
defect depth / p-Werte
S., H.
*1927 (79 y.)
female
SAP 4195582
OS
30˚
Time 11:52 12:28 h
Duration (total / netto) 11:01/11:01 9:09/9:09 m:s
Hintergrund-LD: 10 cd/m≤
Answ. wait. time: 1200 ms
Present.-d.:200 ms
Stimulus size: III
White / White
VA
Correction
0.8
+2.50 sph -1.75 cyl 5˚
Grid: 1215LA 0/1
Nb of questions
Nb of test locations 74 74
4-2-1
Fix 0/90/7 (0%)(23dB)
FP 0/9 (0%), 0/8 (0%)
FN 0/10 (0%), 0/7 (0%)
SF 0.9 0.4
MF 4.4
MS 16.6
MD 6.8
LV 83.5
CLV 81.7
Area 1028 (2152)
Volume 9169 (6973)
Startwerte --
Mean reaction time: --
Classification: Nerve fibre layer defects; Aulhorn II - Absolute defects without connection to the Blind Spot
Pupil diameter:
Fixation during examination
0.0 0.0 0.0 0.0 0.0 0.0
0.0
2.0
4.0
[min]
[mm]
-2.0
2.0
6.0
10.0
14.0
18.0
> =5%
<5%
<2%
<1%
< 0.5 %
10˚ 20˚ 30˚ 28
19 4
27 25
Octopus 101 / tAS / Version 2.2.7 / 2.2.14 (2007)
tAS
Threshold determinating perimetry Octopus 101
defect depth [dB]
p-values [%]
defect depth / p-Werte
S., H.
*1927 (79 y.)
female
SAP 4195582
OS
30˚
Time 10:48 15:43 h
Duration (total / netto) 10:45/10:45 8:30/8:20 m:s
Hintergrund-LD: 10 cd/m≤
Answ. wait. time: 1200 ms
Present.-d.:200 ms
Stimulus size: III
White / White
VA
Correction
0.80
+2.00 sph -1.75 cyl 5˚
Grid: 1215LA 0/1
Nb of questions
Nb of test locations 74 72
4-2-1
Fix 0/90/7 (0%)(22dB)
FP 0/9 (0%), 0/7 (0%)
FN 0/9 (0%), 1/6 (17%)
SF 1.4 1.2
MF 5.4
MS 14.7
MD 8.6
LV 83.0
CLV 78.3
Area 1359 (2152)
Volume 12106 (10946)
Startwerte --
Mean reaction time: --
Classification: Nerve fibre layer defects; Aulhorn II - Absolute defects without connection to the Blind Spot
Pupil diameter:
Fixation during examination
0.0 0.0 0.0 0.0 0.0 0.0
0.0
2.0
4.0
[min]
[mm]
-2.0
2.0
6.0
10.0
14.0
18.0
>= 5 %
<5%
<2%
<1%
< 0.5 %
10˚ 20˚ 30˚ 30
Octopus 101 / tAS / Version 2.2.8 / 2.2.14 (2007)
tAS
Threshold determinating perimetry Octopus 101
defect depth [dB]
p-values [%]
defect depth / p-Werte
S., H.
*1927 (79 y.)
female
SAP 4195582
OS
30˚
Time 11:19 11:35 h
Duration (total / netto) 9:45/9:45 9:25/8:42 m:s
Hintergrund-LD: 10 cd/m≤
Answ. wait. time: 1200 ms
Present.-d.:200 ms
Stimulus size: III
White / White
VA
Correction
0.8
+2.00 sph -1.75 cyl 5˚
Grid: 1215LA 0/1
Nb of questions
Nb of test locations 74 72
4-2-1
Fix 0/80/7 (0%)(22dB)
FP 0/8 (0%), 0/7 (0%)
FN 0/7 (0%), 0/7 (0%)
SF 0.0 0.0
MF 3.9
MS 14.9
MD 8.4
LV 86.9
CLV 86.4
Area 1181 (2152)
Volume 11938 (10200)
Startwerte 09/18/06
Mean reaction time: --
Classification: Nerve fibre layer defects; Aulhorn II - Absolute defects without connection to the Blind Spot
Pupil diameter:
Fixation during examination
0.0 0.0 0.0 0.0 0.0 0.0
0.0
2.0
4.0
[min]
[mm]
-2.0
2.0
6.0
10.0
14.0
18.0
>= 5 %
<5%
<2%
<1%
<0 . 5%
first visit
progression detected
with SCOPE
progression detected
with 6˚x6˚ grid
14 visits within 7.6 years H.S., f, * 1927
Fig. 5 A representative course of progression of glaucomatous visual field defects, examined with additional test points in the visual field area
adjacent to the existing scotomata (scotoma-oriented perimetry (SCOPE). SCOPE finds progression 3.5 years before the conventional 6°×6° grid
1666 Graefes Arch Clin Exp Ophthalmol (2009) 247:1659–1669[13]. Most of our patients had small scotoma areas as can
be seen in the initial staging, and the mean change in the
MD values during the follow-up in our cohort was very
subtle, indicating that there should not be significant
cataract formation effect the estimation of VFD progres-
sion. Finally, any effect of cataract would have influenced
both the 6°×6° and condensed grids fairly equally. The
slightly positive average change of MD may be caused by a
general learning effect.
With every new diagnostic test, it is important to
critically evaluate the test using generally accepted quality
standards. Harper et al. [12] have examined the compliance
with quality standards in ophthalmologic studies, and in
general, only 2.9 of 7 evaluated quality standards were
addressed. This study adheres to five of the seven standards
set forth by Harper et al: (1) specification of the spectrum
composition; (2) avoidance of work-up (verification) bias;
(3) avoidance of review bias; (4) presentation of precision
of results for test accuracy for the most important results,
and (5) reporting of indeterminate test results, which was
not an issue since no indeterminate test results existed. Two
of Harper et al.’s quality standards were not fulfilled: (6)
subgroups were not analyzed separately because of the
small sample size and (7) reproducibility of test results was
not presented separately since, by definition, progression
was based on reproducibility of the test. Harper et al. also
recommended three additional standards: (1) definition of
the gold standard, (2) independence of the gold standard,
i.e., the test under evaluation should not be performed as
part of the gold standard, and (3) appropriateness of the
study population, i.e., avoidance of selection bias. We did
not evaluate the gold standard separately (additional
standard 2), as the condensed test locations were added to
the test locations of the gold standard.
Variability in automated static perimetry in glaucomatous
visual field loss can cause mis-interpretation of progression
of glaucoma [14, 15]. Addition of test locations may result
in both, false-stable and false-progressive results. The
evaluation was focused on the analysis of potential false-
progressive rates, as this condition would result in
additional diagnostic and therapeutic activities, inducing
further costs and also potentially further uncertainty and
discomfort of the patient(s). Thus, confirmation of visual
field loss is essential to avoid false-positive progression and
overtreatment [22]. We could evaluate potential false
progressive results similarly to methods used in earlier
reports [21] that required at least two consecutive visual
fields to indicate progression, but did not have enough
follow-up tests to increase the criterion to the repeatability
in three consecutive visual fields.
Local test point condensation had better stability
compared to conventional grids. Only three eyes that had
confirmed progression by local test point condensation
demonstrated a non-progressive visual field at some time
after confirming progression. Using the final criterion of the
OHTS study [21], locally condensed grids detected pro-
gression in three consecutive examinations in our cohort in
73% of eyes demonstrating progression at some time during
follow-up. Furthermore, after the first confirmation of
progression, locally condensed grids detected progression in
91%ofallthefollowing54consecutive examinations.Thirty-
seven percent of the eyes in our cohort remained stable in all
85 visual field examinations. This repeatability suggests that
the increased number of progressive findings is not due to an
increase in false-positive results. However, as most patients in
our cohort were examined only four to six times, the
possibility of randomness still exists. Thus we cannot rule
out a lower specificity of the locally condensed grid approach
completely. This matter requires further research.
Due to the change in our perimetric instruments (the
TCC was replaced with the Octopus 101), the perimeter
changed in the course of our study in six progressive eyes,
but the test grid was preserved across devices accounting
for the flat screen of the TCC and the cupola of the Octopus
101 perimeter. Progression was already detected in five
eyes before the change of the instrument, and the Octopus
101 confirmed the progression. Progression was detected
after the change to the Octopus 101 in only one eye. In this
case, the condensed grid and the progressive cluster were
located inside 15° of eccentricity, where the risk of spatial
distortion of the grids between the instruments is negligible.
It has been shown that there are only minor differences in
DLS values between the TCC and the Octopus 101 [16], so
the replacement of the TCC with the Octopus 101 should
not have affected the further visual field findings of these
six progressive eyes tested on both devices.
For this study, the examination had to be split into two
sub-sessions to reduce the test durations to reasonable times.
The development of a faster strategy (German adaptive
Threshold Estimation, GATE) [31] to considerably reduce
the examination time makes it possible to apply locally
condensed stimulus arrangements within one session.
Furthermore, test point density can be reduced in “regions
of no interest”, i.e., widespread areas of absolute defects or
areas with repeated confirmed normal DLS values.
It is important to consider the benefit of the increased
effort due to additional test time. Using the same
progression analysis technique and examination sequence,
condensed test grids detected progression on average of 6
visits (41 months) earlier than conventional 6°×6° grid.
Taking the irreversible nature of glaucomatous optic
neuropathy into account, this is a considerable benefit.
Theoretically, increased effort to detect the visual fields’
change could be invested in (a) enhanced spatial resolution,
as is done in this study by local condensation of the test grid;
(b) improving the precision of the threshold estimation of a
Graefes Arch Clin Exp Ophthalmol (2009) 247:1659–1669 1667standard grid; or (c) increasing the frequency of examina-
tions with the standard grid. The concept of the present study
is not adequate to address this question. However, consid-
ering the inherent variability of local threshold estimates,
often exceeding +3 dB (that means half or double of the
original luminance level) it seems to be very unlikely that
clause (b) or (c) are a very successful option. On the other
hand, a spontaneous inter-session fluctuation of scotoma size
is much smaller than fluctuation of scotoma depth.
Therefore, focusing effort on enhanced spatial resolution
as done in this study, is the logical consequence.
An abrupt change of DLS by more than –10 dB
(perimetric event) occurred in more than 50% of eyes
showing progression in our cohort. A comparison with the
literature is difficult, especially due to differing event
criteria. A step size of 10 dB as applied in this study is
the greatest (most conservative) value compared to other
studies [2, 11, 34].
Due to a lack of real-time tracking in conventional
automated perimetry, there is an inherent limitation of
spatial test point condensation: patient-related fixation
instability results in deviations from the fixation target by
a minimum of 1–2° [8]. Therefore, an additional test point
below this critical distance would introduce an “artificial
noise” to the perimetric results and scotoma edges. Future
microperimetric techniques applying real-time fundus
tracking should be able to overcome this shortcoming.
The development of a standardized automated algorithm for
test point condensation (autoSCOPE) is underway.
In conclusion, individually determined locally condensed
grids enable the detection of a glaucomatous visual field
progression more frequently and also earlier than conven-
tional grids at the expense of an increased examination time.
The most common pattern of visual field progression in
glaucoma is a combined deepening and expansion of an
existing scotoma.
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